Table:
begin	end	state
1	11	non-cytoplasmic
12	35	transmembrane
36	64	cytoplasmic
65	87	transmembrane
88	92	non-cytoplasmic
93	117	transmembrane
118	144	cytoplasmic
145	165	transmembrane
166	186	non-cytoplasmic
187	206	transmembrane
207	216	cytoplasmic
217	237	transmembrane
238	243	non-cytoplasmic
244	268	transmembrane
269	300	cytoplasmic
301	328	transmembrane
329	351	non-cytoplasmic
352	372	transmembrane
373	391	cytoplasmic
392	410	transmembrane
411	415	non-cytoplasmic
416	436	transmembrane
437	452	cytoplasmic

Input:
>Echvi_4032 FitnessBrowser__Cola:Echvi_4032
MGQLIIDFSNWIWGWPLLYLLLGGGTLLFLYSGLIPFRGFGHAMKVVGGKYDDPNAKGDI
TSFQALSSAIAATVGLGNISGVALAIGTGGPGAIFWMWVSAFVGMATKYFTCTLAIMYRG
KDSSGHIQGGPMYVIEEGMGKKWRFLSVIFCVAGIMGLLAIFQANQLTDVIRVVLLKPFG
LDHGTTTRWILGVSMMLLVATVILGGIQRIAAVASKLVPFMVTLYFISVLVILFRFGDEI
LPSFWFILEDAFTGKAVLGGSIGAVIITGARRAAFSNEAGIGTAPMVHGASKNEEPVREG
LIAMLGPFIDTIVVCTLTAMTIMVTGVWETGEKDGVLMTLSAFQSGIPVVGKYFLMAAVL
VFALSTMFTYSYYGHKCFNYLFGADKANYYNYFYLLTIVGGAVVSLKVVMSFVDGMYAVM
AFPTMISAIYLSPKVRAATKDYFRRMKEKNTL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server